Glioblastoma cells and immune cells were identified based on the absence of EGFP and presence of B2M, respectively (Fig. 6b, Supplementary Fig. 11a, b), as host feeder organoid cells are engineered to be EGFP-expressing and B2M-deficient. The gene discussed is B2M; the disease is glioblastoma.